Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes

By sjmartinez • April 15, 2025

Zelada H, Campana M, Kawai K, Redden D, Agarwal G, Gutierrez OM, Kumar V. Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes. Clin Transplant. 2025 Apr;39(4):e70144. doi: 10.1111/ctr.70144. PMID: 40230336.

Tags: allograft, diabetes, DOM STAT, Endocrinology, Function, General Internal Medicine, kidney, kidney (allograft) function, posttransplant, Publications

Sperm concentration in mail-in semen consistently reflects results obtained on freshly collected semen

Lue Y, Swerdloff R, Baravarian S, Pak Y, Hull L, Bremner W, Wang C. Sperm concentration in mail-in semen consistently reflects results obtained on freshly[...]

A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes

Abel ED, Ahima RS, Anderson EJ, Berg DD, Berger JS, Das S, Feinberg MW, Fisher EA, Garshick MS, Giannarelli C, Goldberg IJ, Hamburg NM, Kim[...]

Implementation of a cardiovascular toolkit in primary care increased women Veterans’ engagement in behavior change programs: results from a non-randomized stepped wedge trial

Farmer MM, Hamilton AB, Finley EP, Lee ML, Chanfreau C, Than C, Brunner J, Schweizer CA, Moin T, Bean-Mayberry B. Implementation of a cardiovascular toolkit[...]